| Source: |
| Type: |
| miR-107 - MicroRNA-107 Abbreviation: miR-107 Type: MicroRNA / post-transcriptional gene-expression regulator Function: miR-107 is a regulatory microRNA that suppresses target mRNAs through sequence-specific post-transcriptional repression. It influences cell-cycle control, metabolism, angiogenesis, migration, epithelial-mesenchymal transition, neuronal function, and amyloid precursor protein processing. One important neurological target is BACE1, the major β-secretase involved in amyloid-β production. Cancer: ↕ Context-dependent. miR-107 functions as a tumor-suppressive microRNA in many experimental cancers, where increased miR-107 can inhibit proliferation, migration, invasion, angiogenesis, and epithelial-mesenchymal transition. However, oncogenic activity has also been reported in selected tumor types, so its effect depends on the dominant downstream targets and cellular context. Alzheimer's Disease: ↓ Reduced miR-107 has been reported in Alzheimer's disease and may contribute to increased BACE1 expression and amyloidogenic APP processing. Increased miR-107 can suppress BACE1 and is therefore generally considered favorable for reducing amyloid-β production, although miR-107 also regulates additional neuronal and metabolic targets. |
| 7912- | IVT, | Isovitexin modulates autophagy in Alzheimer’s disease via miR-107 signalling |
| - | in-vivo, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1720 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid